REMRF yields 398.88% · PFE yields 6.13%● Live data
📍 REMRF pulled ahead of the other in Year 1
Combined, REMRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of REMRF + PFE for your $10,000?
Atlas Salt Inc., a junior mineral exploration company, engages in the acquisition, evaluation, and exploration of mineral properties in Newfoundland and Labrador, Canada. The company explores for potash, salt, gypsum, and other mineral deposits. It holds 100% interest in the Great Atlantic salt project in the Bay St. George Basin of Western Newfoundland. The company also holds interests in the Ace Gypsum project located in the dormant Flat Bay gypsum mines to the southwest of the Great Atlantic salt deposit; and the Black Bay Nepheline property located in southern Labrador. As of December 31, 2021, the company had 30 mineral licenses approximately 21,725 hectares in the Bay St. George region of Western Newfoundland and in Black Bay, Labrador. The company was formerly known as Red Moon Resources Inc. and changed its name to Atlas Salt Inc. in August 2021. Atlas Salt Inc. was incorporated in 2011 and is headquartered in St. John's, Canada.
Full REMRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.